Cargando…

BCG mediated protection of the lung against experimental SARS-CoV-2 infection

The observation of reduced COVID-19 incidence and severity in populations receiving neonatal intradermal BCG vaccination vaccine raised the question of whether BCG can induce non-specific protection against the SARS-CoV-2 (SCV2) virus. Subsequent epidemiologic studies and clinical trials have largel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hilligan, Kerry L., Namasivayam, Sivaranjani, Sher, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514903/ https://www.ncbi.nlm.nih.gov/pubmed/37744331 http://dx.doi.org/10.3389/fimmu.2023.1232764

Ejemplares similares

Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge
por: Hilligan, Kerry L., et al.
Publicado: (2021)

Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge
por: Hilligan, Kerry L., et al.
Publicado: (2021)

Helminth exposure protects against murine SARS-CoV-2 infection through macrophage dependent T cell activation
por: Hilligan, Kerry L., et al.
Publicado: (2022)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2
por: Pichler, Renate, et al.
Publicado: (2023)

BCG vaccination provides protection against IAV but not SARS-CoV-2
por: Kaufmann, Eva, et al.
Publicado: (2022)

BCG Vaccine Derived Peptides Induce SARS-CoV-2 T Cell Cross-Reactivity
por: Eggenhuizen, Peter J., et al.
Publicado: (2021)

Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19
por: Du, Jingli, et al.
Publicado: (2023)

Protection against SARS-CoV-2 by BCG vaccination is not supported by epidemiological analyses
por: Hensel, Janine, et al.
Publicado: (2020)

Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads
por: Baker, Paul J., et al.
Publicado: (2023)

Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques
por: White, Andrew D., et al.
Publicado: (2022)

Persistent Oxidative Stress and Inflammasome Activation in CD14(high)CD16(−) Monocytes From COVID-19 Patients
por: Lage, Silvia Lucena, et al.
Publicado: (2022)

A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants
por: Shan, Sisi, et al.
Publicado: (2021)

Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
por: Ahluwalia, Pankaj, et al.
Publicado: (2021)

Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
por: Abebe, Endeshaw Chekol, et al.
Publicado: (2023)

Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice
por: Dubuc, Isabelle, et al.
Publicado: (2022)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
por: Ma, Qinhai, et al.
Publicado: (2023)

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety
por: Svorcova, Monika, et al.
Publicado: (2022)

Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2
por: Tarabini, Renata Fioravanti, et al.
Publicado: (2022)

Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults
por: Rakshit, Srabanti, et al.
Publicado: (2022)

BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine?
por: Kamat, Siya, et al.
Publicado: (2020)

Heterologous Boosting With Listeria-Based Recombinant Strains in BCG-Primed Mice Improved Protection Against Pulmonary Mycobacterial Infection
por: Liu, Si-Jing, et al.
Publicado: (2020)

Cyclic di-AMP as endogenous adjuvant enhanced BCG-induced trained immunity and protection against Mycobacterium tuberculosis in mice
por: Ning, Huanhuan, et al.
Publicado: (2022)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Prospects of Neutralizing Nanobodies Against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2021)

Defending against SARS-CoV-2: The T cell perspective
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2023)

The Microbiome and Tuberculosis: Early Evidence for Cross Talk
por: Namasivayam, Sivaranjani, et al.
Publicado: (2018)

DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice
por: Chen, Jinni, et al.
Publicado: (2022)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
por: Martín-Galiano, Antonio J., et al.
Publicado: (2021)

Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2023)

Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity
por: Scaglione, Antonella, et al.
Publicado: (2021)

Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy
por: Lee, Mi-Hyun, et al.
Publicado: (2023)

Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
por: Kaufmann, Stefan H. E.
Publicado: (2020)

Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis
por: Negi, Kriti, et al.
Publicado: (2022)

Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaques
por: He, Qian, et al.
Publicado: (2022)

A nasal vaccine with inactivated whole-virion elicits protective mucosal immunity against SARS-CoV-2 in mice
por: Tokunoh, Nagisa, et al.
Publicado: (2023)

BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse
por: Converse, Paul J., et al.
Publicado: (2011)

BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity
por: Abate, Getahun, et al.
Publicado: (2019)

BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design
por: Covián, Camila, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ihkidnurofuhr98ldus88aa61n